Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Dose Escalation Study of No-Carrier-Added 131I-Metaiodobenzylguanidine for Relapsed or Refractory Neuroblastoma: New Approaches to Neuroblastoma Therapy Consortium Trial, Journal of Nuclear Medicine, June 2012, Society of Nuclear Medicine,
DOI: 10.2967/jnumed.111.098624.
You can read the full text:
Contributors
The following have contributed to this page
